期刊文献+

补肾活血化痰汤和尼莫地平治疗血管性认知障碍的对比研究 被引量:5

Case-control Study on the Treatment of Vascular Cognitive Impairment between Bushenhuoxuehuatan Decoction and Nimodipine
暂未订购
导出
摘要 目的通过观察补肾活血化痰汤在治疗血管性认知障碍患者的疗效。方法将40例血管性认知障碍患者随机分为两组,治疗组口服补肾活血化痰汤合尼莫地平治疗,对照组口服尼莫地平治疗,疗程8周,使用MMSE量表对患者进行认知功能测评。结果治疗组总有效率高于对照组;两组治疗后MMSE评分明显升高(P<0.01),治疗后治疗组评分明显高于对照组(P<0.05)。结论补肾活血化痰汤和尼莫地平均能较好缓解血管性认知障碍患者的临床症状,但补肾活血化痰汤配合尼莫地平的治疗效果优于单纯使用尼莫地平治疗。 Objective: To observe the treatment of Bushenhuoxuehuatan Decoction in the Vascular Cognitive Impairment,evaluate the clinical efficacy of Bushenhuoxuehuatan Decoction in the Vascular Cognitive Impair- ment. Methods: All 40 Vascular Cognitive Impairment patients were randomly divided into two groups:the treat- ment group in which 20 cases and the control group in which 20 cases. The treatment group was treated with Ni- modipine and Bushenhuoxuehuatan Decoction,the control group was treated with Nimodipine. The two groups were treat for 8 weeks. MMSE was used for the assessment of cognitive function. Results: The effective rate of the treatment group was significantly higher than the control group. After treatment,the MMSE scores of two groups were significantly higher than before treatment (P〈 0.01 ),the treatment group score was significantly higher than the control group (P 〈 0.05). Conclusion: Bushenhuoxuehuatan Decoction and Nimodipine can better alleviate Vascular Cognitive Impairment in patients with clinical symptoms,but Bushenhuoxuehuatan Decoction with Ni- modipine treatment is better than simply using Nimodipine.
出处 《中国中医急症》 2013年第11期1855-1856,共2页 Journal of Emergency in Traditional Chinese Medicine
基金 广东省中医药局建设中医药强省科研项目(2009098)
关键词 血管性认知障碍 补肾活血化痰法 尼莫地平 Vascular Cognitive Impairment Bushenhuoxuehuatan Decoction Nimodipine
  • 相关文献

参考文献5

  • 1Bowler JV. The concept of vascular cognitive impaiment [J]. Neurological Sciences, 2002, (203-204) : 11-15.
  • 2Rockwood K, Howard K, MacK C, et al. Spectrum of disease in vascular cognitive impairment [ J ]. Neuroepide miology, 1999,18(5) :245-254.
  • 3贾建平.重视血管性认知障碍的早期诊断和干预[J].中华神经科杂志,2005,38(1):4-6. 被引量:267
  • 4.中药新药临床研究指导原则:第2辑[S].[S].中华人民共和国卫生部制定发布,1995.431.
  • 5Pantomi L, del Ser T, Soglian, et al. Efficacy and safety of ni- modipine in subcortical vascular dementia:A randomized placebo-contraolled trial[ J ]. Stroke, 2005,36 : 619-624.

二级参考文献13

  • 1O' Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol, 2003, 2:89-98.
  • 2Bowler JV, Munoz DG, Merskey H, et al. Fallacies in the pathological conilrmation of the diagnosis of Alzheimer's disease. J Neurol Neurosurg Psychiatry, 1998, 64 : 18-24.
  • 3Barba R, Martinez-Espinosa S, Rodriguez-Garcia E, et al. Poststroke dementia: clinical features and risk factors. Stroke,2000,31 : 1494-1501.
  • 4Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 1993, 43:250-260.
  • 5Kalaria RN. The role of cerebral ischemia in Alzheimer' s disease. Neurobiol Aging, 2000, 21:321-330.
  • 6DeCarli Charles. The role of cerebrovascular disease in dementia. Neurologist. 2003, 9: 123-136.
  • 7Pantoni L, Lammie A. Cerebral small vessel disease: pathological and pathophysiological aspects in relation to vascular cognitive impairment. In: Erkinjunti T, Gauthier S, eds. Vascular cognitive impairment. London : Martin Duniz Publishers, 2002. 1115-1134.
  • 8Roman GC, Royall DR. Executive control function: a rational basis for the diagnosis of vascular dementia. Alzheimer Dis Assoc Disord,1999,13 Suppl 3 :S69-S80.
  • 9Erkinjantti T. Diagnosis and management of vascular cognitive impairment and dementia. J Neural Transm Suppl, 2002, 63:91-109.
  • 10Rockwood K, Howard K, MacKnight C, et al. Spectrum of disease in vascular cognitive impairment. Neuroepidemiology, 1999, 18:248-254.

共引文献292

同被引文献61

引证文献5

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部